We believe that Johnson & Johnson stock (NYSE: JNJ) is currently a better pick than Procter & Gamble stock (NYSE: PG) as it appears to show more promise over the coming years. The decision to invest often comes down to finding the best stocks within the scope of certain characteristics that suit an investment style.
I rank a selection of undervalued dividend growth stocks in the Dividend Radar and present the ten top-ranked stocks for consideration. To rank stocks, I do a quality assessment and sort stocks by quality scores, breaking ties with additional metrics. This month, I'm presenting the ten top-ranked undervalued dividend growth stocks in Dividend Radar.
Strong companies with profitable businesses and a path to future growth can drive investor returns over the long run. Johnson & Johnson is still working to resolve talc claims, but its business is doing extremely well, and its balance sheet can weather the storm.
The former president's recent regulatory filing disclosed positions in 21 Dividend Kings. Most of these stocks underperformed the S&P 500 over the last five years.
Johnson & Johnson faces challenges related to a new law in the U.S. The company can find ways to navigate this problem. The stock remains a great pick for income seekers.
Johnson & Johnson said on Friday it is negotiating with plaintiffs' lawyers who have opposed the company's proposed settlement of lawsuits alleging its baby powder and other talc products caused cancer, seeking to eliminate holdouts to the deal.
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.